Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100


Femoropopliteal In-stent Restenosis Repair: Midterm Outcomes After Paclitaxel Eluting Balloon Use (PLAISIR Trial).

Bague N, Julia P, Sauguet A, Pernès JM, Chatelard P, Garbé JF, Penillon S, Cardon JM, Commeau P, Planché O, Guyomarch B, Gouëffic Y.

Eur J Vasc Endovasc Surg. 2017 Jan;53(1):106-113. doi: 10.1016/j.ejvs.2016.10.002. Epub 2016 Nov 24.


Percutaneous occlusion of the left atrial appendage: An expert consensus statement.

Klug D, Commeau P, Defaye P, Thambo JB, Gras D, Aubry P, Pasquie JL, Guerin P, Teiger E, Koning R, Piot O; Heart Rhythm, Pacing Group, the Atheroma, Interventional Cardiology Group of the French Society of Cardiology..

Arch Cardiovasc Dis. 2015 Aug-Sep;108(8-9):460-7. Review.


Management of Takotsubo cardiomyopathy in non-academic hospitals in France: The Observational French SyndromEs of TakoTsubo (OFSETT) study.

Yayehd K, N'da NW, Belle L, Bataille V, Hanssen M, Leddet P, Aupetit JF, Commeau P, Filippi E, Georges JL, Albert F, Rangé G, Meimoun P, Marcaggi X, Baleynaud S, Nallet O, Dibie A, Barnay C, Jouve B, Legrand M, Cattan S, Mulak G, Simon T, Danchin N, Dujardin JJ; OFSETT investigators..

Arch Cardiovasc Dis. 2016 Jan;109(1):4-12. doi: 10.1016/j.acvd.2015.08.004. Epub 2015 Oct 23.


Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study.

Naber CK, Pyxaras SA, Nef H, IJsselmuiden AJ, Briguori C, Schlundt C, Wykrzykowska J, Eberli FR, Möllmann H, Galatius S, Rieber J, Commeau P, van Geuns RJ, Bouchez D, Mudra H.

EuroIntervention. 2016 Jun 20;12(3):356-8. doi: 10.4244/EIJY15M06_02.


A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial.

Chevalier B, Dimario C, Neumann FJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Coe J, Schwartz LB; ZOMAXX I Investigators..

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1039-47. doi: 10.1002/ccd.24958. Epub 2013 Jul 25.


A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial.

Scheinert D, Katsanos K, Zeller T, Koppensteiner R, Commeau P, Bosiers M, Krankenberg H, Baumgartner I, Siablis D, Lammer J, Van Ransbeeck M, Qureshi AC, Stoll HP; ACHILLES Investigators..

J Am Coll Cardiol. 2012 Dec 4;60(22):2290-5. doi: 10.1016/j.jacc.2012.08.989.


Expert consensus: Renal denervation for the treatment of hypertension.

Pathak A, Girerd X, Azizi M, Benamer H, Halimi JM, Lantelme P, Lefevre T, Sapoval M; Société Française d’Hypertension Artérielle.; Société Française de Cardiologie.; Groupe Athérome Coronaire et Interventionnel.; Société Française de Radiologie..

Diagn Interv Imaging. 2012 May;93(5):386-94. doi: 10.1016/j.diii.2012.03.013. Epub 2012 May 4.


[Role of angioplasty in the treatment of renal artery stenosis].

Armero S, Bonello L, Paganelli F, Barragan P, Roquebert PO, Commeau P.

Ann Cardiol Angeiol (Paris). 2011 Dec;60(6):361-5. doi: 10.1016/j.ancard.2011.09.010. Epub 2011 Oct 18. French.


[Management of acute myocardial infarction. How improve primary angioplasty?].

Commeau P.

Presse Med. 2011 Jun;40(6):606-10. doi: 10.1016/j.lpm.2011.02.034. Epub 2011 Apr 16. Review. French.


Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).

Spaulding C, Teiger E, Commeau P, Varenne O, Bramucci E, Slama M, Beatt K, Tirouvanziam A, Polonski L, Stella PR, Clugston R, Fajadet J, de Boisgelin X, Bode C, Carrié D, Erglis A, Merkely B, Hosten S, Cebrian A, Wang P, Stoll HP, Henry P.

JACC Cardiovasc Interv. 2011 Jan;4(1):14-23. doi: 10.1016/j.jcin.2010.10.007.


Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review.

Naggara O, Touzé E, Beyssen B, Trinquart L, Chatellier G, Meder JF, Mas JL; EVA-3S Investigators..

Stroke. 2011 Feb;42(2):380-8. doi: 10.1161/STROKEAHA.110.588772. Epub 2010 Dec 23. Review.


Usage patterns and 1-year outcomes with the TAXUS Liberté stent: results of the TAXUS OLYMPIA registry.

Ahmed WH, Mendiz OA, Thomas MR; TAXUS OLYMPIA Participating Physicians..

Catheter Cardiovasc Interv. 2011 Jun 1;77(7):979-92. doi: 10.1002/ccd.22805. Epub 2010 Dec 3.


Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients.

Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, Agostoni P, Bosiers M, Peregrin J, Rosales O, Cotroneo AR, Rand T, Sheiban I.

J Endovasc Ther. 2009 Jun;16(3):251-60. doi: 10.1583/09-2691.1. Review.


Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter.

Chevalier B, Gilard M, Lang I, Commeau P, Roosen J, Hanssen M, Lefevre T, Carrié D, Bartorelli A, Montalescot G, Parikh K.

EuroIntervention. 2008 Aug;4(2):222-8.


Endovascular procedures for below the knee arteries in diabetics.

Commeau P.

Ann Cardiol Angeiol (Paris). 2008 Dec;57(6):352-8. doi: 10.1016/j.ancard.2008.09.008. Epub 2008 Oct 23. Review.


Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial.

Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touzé E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, Hénon H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G; EVA-3S investigators..

Lancet Neurol. 2008 Oct;7(10):885-92. doi: 10.1016/S1474-4422(08)70195-9. Epub 2008 Sep 5.


Multicenter safety and efficacy analysis of assisted closure after antegrade arterial punctures using the StarClose device.

Williams RE, Angel CY, Bourkaib R, Brenot P, Commeau P, Fisher RK, Jackson R, Kay CH, Le Dref O, Riou JY, Rose J, Macdonald S.

J Endovasc Ther. 2007 Aug;14(4):498-505.


Sirolimus for below the knee lesions: mid-term results of SiroBTK study.

Commeau P, Barragan P, Roquebert PO.

Catheter Cardiovasc Interv. 2006 Nov;68(5):793-8.


ISR II study: a long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions.

Commeau P, Barragan PT, Roquebert PO, Siméoni JB.

Catheter Cardiovasc Interv. 2005 Oct;66(2):158-62.


Usefulness and clinical impact of a fractional flow reserve and angiographic targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registry.

Dupouy P, Gilard M, Morelle JF, Furber A, Aptecar E, Cazaux P, Slama M, Feldman LJ, Wittenberg O, Pernès JM, Huret B, Commeau P, Boschat J, Teiger E, Lafont A, Steg PG, Dubois Randé JL.

EuroIntervention. 2005 May;1(1):85-92.


Supplemental Content

Loading ...
Support Center